Opko Health OPK Pharmaceutical — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's pharmaceutical — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's pharmaceutical — total assets?
- Opko Health (OPK) reported pharmaceutical — total assets of $1.3B in Q1 2026.
- What is the long-term trend for Opko Health's pharmaceutical — total assets?
- Over 3 years (2021 to 2024), Opko Health's pharmaceutical — total assets has grown at a 4.5% compound annual growth rate (CAGR), from $4.53B to $5.17B.
- What does pharmaceutical — total assets mean?
- This metric represents the total value of resources owned or controlled by the pharmaceutical segment, including property, plant, equipment, inventory, and intangible assets. It serves as a measure of the scale and capital base dedicated to pharmaceutical research, development, and commercialization. Analyzing this figure allows for the assessment of asset utilization and the segment's overall contribution to the company's balance sheet.